Exercise as Treatment for Patients With Inclusion Body Myositis
Launched by OSLO UNIVERSITY HOSPITAL · Oct 14, 2024
Trial Information
Current as of June 07, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how exercise can help people with Inclusion Body Myositis (IBM), a condition that causes muscle weakness and makes it hard to move. The study involves a 16-week exercise program at Oslo University Hospital, where participants will take part in weekly exercise sessions led by experienced physiotherapists. The goal is to see if this exercise can improve muscle strength, fitness, and balance for those living with IBM. Participants are also encouraged to do some exercises at home between sessions to further enhance their physical fitness.
To join the study, you need to have a diagnosis of IBM and be able to walk with the help of aids, like a walker or cane. Unfortunately, if you cannot understand or write in Norwegian, you won’t be able to participate. Throughout the trial, researchers will gather feedback through interviews, physical tests, and questionnaires to understand how effective the exercise program is and if it really helps improve the quality of life for those with IBM. This is an exciting opportunity to explore the benefits of exercise for a condition that currently has limited treatment options.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • IBM diagnosis
- • Able to walk with aids
- • Exclusion Criteria
- • -Unable to understand and write Norwegian
About Oslo University Hospital
Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported